Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 1st Quarter

9 Feb 2021 07:00

RNS Number : 3742O
Income & Growth VCT (The) PLC
09 February 2021
 

LEI: 213800FPC15FNM74YD92

 

The Income & Growth VCT PLC

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2020

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2020. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 December 2020

At 30 September 2020

 

Net assets attributable to shareholders

 

£93,681,750

£83,133,430

Shares in issue

118,325,511

118,661,711

Net asset value (NAV) per share

 

79.17p

70.06p

Cumulative dividends paid to date per share since inception

131.50p

131.50p

Total return per share since inception (NAV basis)

210.67p

201.56p

 

The NAV per share has increased by 9.11 pence in the quarter (an increase of 13% upon the opening NAV per share). This is principally due to a rise in unrealised portfolio valuations as well as gains on realisations (further details below).

 

SHARE BUY-BACKS

 

On 16 December 2020, the Company bought back 336,200 of its own ordinary shares at a price of 66.56 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investments during the period

On 22 December 2020, the Company made a new investment of £0.47 million into Northern Bloc Ice Cream Limited, a dairy-free ice cream manufacturer.

 

On 30 December 2020, the Company made a new investment of £1.16 million into Connect Childcare Group Limited, a provider of nursery management software.

 

Realisations during the period

On 27 November 2020, the Company sold its investment in Vectair Holdings Limited, generating cash proceeds of £1.10 million. Over the fifteen years this investment was held, it generated cash proceeds of £1.79 million compared to an original investment cost of £0.22 million, which is a multiple on cost of 8.3x and an IRR of 22.2%

 

On 29 December 2020, the Company sold its investment in Bourn Bioscience Limited, generating cash proceeds of £2.14 million. Over the nearly seven years this investment was held, it generated cash proceeds of £2.64 million compared to an original investment cost of £1.61 million, which is a multiple on cost of 1.6x and an IRR of 8.5%.

 

 

Loan repayments and further proceeds during the period

On 16 October 2020, the Company received loan repayment proceeds of £0.21 million from Vian Marketing Limited (trading as Red Paddle Co.).

 

On 14 December 2020, the Company received deferred consideration of £0.09 million from Redline Worldwide Limited, an investment realised in a previous year.

 

Further investments after the period end

On 7 January 2021, the Company made a further investment of £0.36 million into Parsley Box Limited, a supplier of home-delivered ambient meals for the elderly.

 

On 5 February 2021, the Company made a further investment of £0.15 million into Bleach London Holdings Limited, a hair colourants brand.

 

Loan repayments and further proceeds after the period end

After the period end, on 26 January 2021, the Company received a loan repayment of £0.06 million in respect of BG Training Limited.

 

Also after the period end, on 27 January 2021, the Company received further proceeds of £0.14 million in respect of Blaze Signs Holdings Limited, an investment realised in a previous year.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFUWVNRAKUURAR
Date   Source Headline
15th May 201812:13 pmRNSHalf-year Report
27th Mar 20184:53 pmRNSTransaction in Own Shares
13th Mar 20184:28 pmRNSIssue of Equity
15th Feb 20185:14 pmRNSDirector/PDMR Shareholding
15th Feb 20185:14 pmRNSIssue of Equity
13th Feb 20189:19 amRNSTransaction in Own Shares
7th Feb 20181:36 pmRNSInterim Management Statement
7th Feb 20181:26 pmRNSAGM Statement
25th Jan 20189:23 amRNSIssue of Equity
5th Jan 201812:38 pmRNSRealisation of investment in Gro-Group
5th Jan 201811:25 amRNSTotal Voting Rights
20th Dec 20175:53 pmRNSTransaction in Own Shares
20th Dec 20171:58 pmRNSPublication of Suppl.Prospcts
14th Dec 20174:53 pmRNSNational Storage Mechanism
12th Dec 201712:41 pmRNSAnnual Financial Report
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:31 amRNSIssue of Equity
21st Nov 201710:05 amRNSIssue of Equity
10th Nov 201710:37 amRNSIssue of Equity
1st Nov 201712:45 pmRNSIncrease in Offer size. Expiry of early incentive.
23rd Oct 201711:34 amRNSOver-allotment facility
20th Oct 20172:25 pmRNSIssue of Equity
2nd Oct 20174:53 pmRNSTransaction in Own Shares
29th Sep 20179:19 amRNSIssue of Equity
21st Sep 20177:00 amRNSInterim Management Statement
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
1st Sep 20178:53 amRNSTotal Voting Rights
31st Aug 20173:47 pmRNSDirector/PDMR Shareholding
31st Aug 20173:43 pmRNSDirector/PDMR Shareholding
31st Aug 20173:40 pmRNSIssue of Equity
4th Aug 20175:11 pmRNSJoint Announcement - Fundraising Update
3rd Aug 20174:46 pmRNSNotice of Results
3rd Aug 20171:58 pmRNSDividend Declaration
3rd Aug 20171:57 pmRNSNet Asset Value(s)
1st Aug 20179:30 amRNSTotal Voting Rights
10th Jul 20174:07 pmRNSTransaction in the Company's own shares
7th Jul 201710:46 amRNSFundraising Update, Circular and General Meetings
5th Jul 201711:34 amRNSRealisation of investment in Entanet Holdings Ltd
3rd Jul 20174:59 pmRNSTotal Voting Rights
20th Jun 20175:55 pmRNSDirector/PDMR Shareholding
20th Jun 20175:46 pmRNSIssue of Equity
24th May 20171:07 pmRNSIntention to launch offers for subscription
24th May 201711:08 amRNSHalf-year Report
16th May 20171:37 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.